Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Similar documents
Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

The Complete Blood Count

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Year 2003 Paper two: Questions supplied by Tricia

Communiqué. How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Deconstructing the CBC

Diagnostic Approach to Patients with Anemia

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Approach to the abnormal CBC

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Disorders of Blood Cells & Blood Coagulation

Hematologic changes in systemic diseases. Chittima Sirijerachai

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

3 Ruba hussein Dr. ahmad Dr. ahmad

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

2013 AAIM Pathology Workshop

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

Blood Cell Identification Graded

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Approach to a pale child

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Leukocytosis - Some Learning Points

The Evaluation and Classification of Anemia

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

Interpreting an Abnormal CBC

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Platelet and WBC disorders

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital

Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016

Interpreting Blood Tests Part 1. Dr Andrew Smith

The Irony of Anemia How to interpret the CBC

Polycthemia Vera (Rubra)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

Clinical & Laboratory Assessment

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

Continuing Education Questions

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

General Characterisctics

Diseases Of The Blood

Complete Blood Count PSI AP Biology

5/5/2010. Goldilocks picture from

Solving Medical Mysteries Deducing diagnoses from clues in the CBC. Donald S. Houston MD PhD FRCPC

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

Hematology Unit Lab 1 Review Material

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017

Myelodysplastic Syndrome: Let s build a definition

Faculty of Medicine Dr. Tariq Aladily

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter

ASPEN MOUNTAIN MEDICAL CENTER. Lab Health Fair

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Complete Blood Count (CBC)

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

Anemia In the Insurance Applicant What do the numbers mean?

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Hematology: Challenging Cases with Your Participation COPYRIGHT

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Does Morphology Matter in 2017

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Introduction and Approach to Anemia

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass.

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Complete Blood Count (CBC) Assist.Prof. Filiz BAKAR ATEŞ

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

بسم هللا الرحمن الرحيم

The Child with a Hematologic Alteration

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

Peripheral Blood Smear: Diagnostic Clues and Algorithms

Peripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital

Cbc with differential

Updates for your practice August 2013 TLALELETSO. HIV & Anemia. Continued on Page 2

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

Microcytic Hypochromic Anemia An Approach to Diagnosis

Problem Based Learning

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

PNH Glossary of Terms

FBC CASES Vernon Louw Clinical Haematology 2010

CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

PCCN Review Hematology

Transcription:

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside

Blood Cell Abnormalities Abnormalities of production Parts? Factory? Abnormalities related to loss Bleeding? Sequestration? Abnormalities related to destruction Autoimmune/Idiopathic?

Variables to focus on Hgb and Hct MCV RBC distribution width (RDW) Platelets WBC with differential Patients baseline, differences based on sex and race. If abnormality exists out of context, repeat the test.

Coulter counter Counts circulating blood cells by electrical pulse The height of the pulse indicates cell volume Newer counters give multimodal assessment of cell size and content which is the differential. 5 part differential includes neutrophils, lymphocytes, monocytes, eosinophils and basophils

Stick The Tube In The Machine- And Let IT Do Magic Automated Hematology Analyzer 2 CHAMBERS In one chamber, the red cells are counted. The detecter is set to count merely the cells the size limits of Red Blood Cells. In the other chamber, the blood is put into a solution that lyses the red blood cell leaving merely WBC and platelets intact.

Approaches to evaluation History Physical exam Review of differential and peripheral smear as appropriate Additional tests as appropriate Depending on results, Hematology referral.

Platelet Abnormalities

Thrombocytopenia Definition: Platelet count < 150,00 Asymptomatic Thrombocytopenia Found on routine CBC Symptomatic Thrombocytopenia Bleeding, bruising or petechiae

Thrombocytopenia Decreased platelet production Viral infection, HIV, Hep C, Parvovirus Leukemia, Vitamin deficiency Increased Platelet Destruction Drugs: Heparin, Valproic acid Autoimmune destruction ( TTP, ITP, Lupus) DIC Platelet loss / Psuedothrombocytopenia Platelet clumping (EDTA induced), Pregnancy Splenic sequestration

Critical Values Surgeons will generally consider platelet number to be adequate if >50,000 Spontaneous bleeding does not occur unless platelet count is < 20,000 Transfuse platelets if <10,000 or spontaneous bleeding

Laboratory evaluation for Thrombocytopenia CBC with manual differential, PT/PTT and review of Peripheral smear Evaluate for drug induced thrombocytopenia and hypersplenism Abdominal ultrasound Rule out HIV infection, lymphoproliferative disorder and autoimmune disease. HIV testing, ANA and SPEP

Points to remember. TTP/hemolytic uremic syndrome need urgent therapy. Idiopathic thrombocytopenic purpura is a diagnosis of exclusion. ITP: less likely to bleed spontaneously as platelets are often young and vigorous! Bone Marrow biopsy or platelet antibody tests are not indicated in most work-ups of ITP. It is appropriate to initiate work-up but most situations should be referred to Hematology.

Thrombocytosis Marrow over production Myeloproliferative disorder Can be a result of something else going on (Reactive Thrombocytosis) Seen in iron deficiency Seen in post surgical patients Seen in infection Seen in trauma

Thrombocytosis Defined as >450,000 but evaluation is not necessarily indicated unless near 600,000 Primary Thrombocytosis versus Reactive Thrombocytosis Elevated platelet count can be due to a myeloid malignancy or myeloproliferative process Elevated platelet count can be due to a secondary process such as: Iron Deficiency Anemia Infection/Inflammation/Tissue Damage Hemolysis Nonmyeloid malignancy Splenectomy

Thrombocytosis continued The difference between primary thrombocytosis and reactive thrombocytosis is clinically relevant because primary thrombocytosis is associated with increased risk of thrombohemorragic complications and reactive thrombocytosis is not.

Clinical evaluation of Thrombocytosis Patient History Old medical record will determine if a new or longstanding problem Splenectomy? Chronic thrombocytosis in patients with a spleen is highly suggestive of primary thrombocytosis. Chronic thrombocytosis in patient without a spleen is a benign condition.

Laboratory evaluation CBC Increased HGB, MCV or WBC or immature WBC, suggests Primary Thrombocytosis/Myeloproliferative disorder Serum Ferritin Rule out iron deficiency C-Reactive Protein Elevation indicates an inflammatory cause Normal levels are seen in a marrow disorder

If no cause can be found for a reactive process, refer. Hematology evaluation will likely include: JAK 2 testing Bone Marrow biopsy Bcr/Abl

Primary Thrombocytosis Myeloproliferative disorders Essential Thrombocytosis Polycythemia Vera Primary Myelofibrosis Myeloid Malignancies MDS CML

White Blood Cell Abnormalities

Leukopenia/Neutropenia Leukopenia refers to a low total WBC Granulocytopenia refers to a decrease in circulating neutrophils, eosinophils and basophils Neutropenia refers to a decrease in circulating neutrophils ANC or absolute neutrophil count = Total WBC x percent (polys + bands) / 100

Points to remember Patients with moderate to severe neutropenia will not demonstrate classic signs of infection other than fever. Ethnic variations: African Americans, Yemenite Jews, Ethiopians and certain Arabs normally have a slightly lower WBC and ANC. Benign Ethnic Neutropenia (ANC not <500)

Acquired vs congenital Neutropenia Congenital neutropenias are rare Acquired causes: Drugs or infections (virus, sepsis) are more common Immune disorders: HIV, Chronic Idiopathic Neutropenia Leukemia or other hematologic malignancies rarely present with isolated neutropenia

Lymphopenia Often caused by immune suppressive drugs including steroids and antilymphocyte monoclonal antibodies HIV Critical illness Connective tissue diseases Lymphopenia seen in elderly patients, where it is usually of no clinical significance. No further investigation is advised in an elderly patient with a lymphocyte count >0.5 109/L in the absence of any concerning symptoms Persistent lymphopenia that remains stable over a six month period and in the absence of symptoms, clinical findings, or abnormal results from investigations does not require further investigation

Diagnostic Approach If leukopenia, neutropenia or granulocytopenia is identified along with other blood abnormalities such as normocytic anemia and/or thrombocytopenia, a peripheral smear and an immediate referral to a hematologist for a bone marrow biopsy should be done. Mild neutropenia without recurrent infections or protracted infection can be observed.

Diagnostic Approach cont If observation is appropriate ANC should be checked at least 2-3 times per week for 6-8 weeks. If neutropenia persists, refer to Hematologist for a bone marrow biopsy and further evaluation. Moderate to severe neutropenia with infection should be referred directly to Hematologist for bone marrow biopsy and further evaluation.

Leukocytosis First step in evaluation is to determine which WBC type is increased. The increase maybe secondary to immature precursors (blasts) or an expansion of mature leukocytes such as granulocytes, lymphocytes, monocytes. Manual differential and review of peripheral smear will help classify and rule out acute leukemia.

Leukocytosis Total WBC > 11,000 Leukocytosis commonly is due to an increase in the number of circulating neutrophils Leukocytosis can also be due to an increase in other white blood cell such as lymphocytes, eosinophils, monocytes or rarely basophils.

Causes to consider: Normal variation By definition 2.5% of the population will be greater than 2 SD above the mean Blood sampling problem Platelet clumping Infection or inflammation Total WBC + CRP + Neutrophils Drugs Bone Marrow disorder

Specific differential abnormalities Neutrophilic leukocytosis: infection, stress, smoking, pregnancy, PV and CML Lymphocytic leukocytosis: Infections such as mono, ALL, CLL, NHL Monocytic leukocytosis: Acute bacterial infections, TB, AML and CML/MDS Eosinophilic or basophilic leukocytosis: paracytic infections, allergic reactions, solid tumors, forms of chronic and acute leukemia's (HES)

Red Blood Cell Abnormalities

Anemia's Various definitions (hemoglobin and hematocrit levels) < 12 in women and < 14 in men Production problems, destruction problems or loss Classification: Normocytic, Macrocytic, Microcytic

Anemia Parameters Print out from out from machine RBC counted (coulter) HB measured (light abs) MCV from size distribution

Initial questions to ask: Is the patient bleeding? Is there evidence for RBC destruction/hemolysis? Is the bone marrow suppressed? Is there iron deficiency? If so why? Is there B12 or folate deficiency? If so why?

Initial test to order Complete Blood Count with differential Iron studies with ferritin B 12 and Folate Reticulocyte count CMP (creatinine, total protein, LFT s) TSH Additional studies depending on these results.

What Test Tells Production v Destruction? Reticulocytes Reticulocytes are immature red blood cells, typically composing about 1% of the red cells Reticulocytes mature in bone marrow and then circulate for about a day in the blood stream They are called reticulocytes because of a reticular (mesh-like) network of ribosomal RNA that becomes visible under a microscope with certain stains such as new methylene blue This test must be ordered separately Modern instruments can automate the process

Microcytic Anemia Definition: MCV < 80 Caused by: Iron deficiency Thalassemia Chronic disease Serum ferritin should be the first test to check as part of initial work-up. Iron deficiency is unlikely in the presence of persistently normal or elevated serum ferritin.

What do you see? Microcytosis and increase in RDW Classic Iron deficiency anemia MCV= 72

Iron Deficiency Anemia (IDA) Most common form of anemia Should be ruled out initially in every anemia workup. Can see iron deficiency combined with other types of anemia # 1 cause of iron deficiency is bleeding The cause of bleeding should be sought in every case.

IDA continued Always trial oral iron unless patient has documented absorption problem Parenteral iron can replenish iron stores in 1 dose. But not risk free. Standard of care is to replace iron stores. Don t transfuse. Note- it will take 1-2 mos for HB to rise, be patient If patient is bleeding, stop the bleeding first as they will not retain the iron you give them!

Thalassemia This should be considered if patient is microcytic but not iron deficient. Patient can have Thalassemia and IDA. Iron deficiency must be corrected before testing for Thalassemia. History is very important in identifying Thalassemia Don t give iron unless iron deficient. Use Hematologist to interpret Hgb electrophoresis

Microcytic anemia of chronic disease Otherwise known as anemia of inflammation These are anemias of Chronic Inflammatory diseases, like RA. THIS IS NOT CHF, HTN, DM which are chronic diseases, not characterized by inflammation Usually iron studies demonstrate: Low serum iron, low total iron binding capacity and increased serum ferritin. However, ferritin could be elevated by inflammatory process itself. Bone marrow biopsy maybe necessary to rule out iron deficiency.

Macrocytic Anemia Definition: MCV > 100 Caused by: B12 or folate deficiency (consider MMA levels) Hypothyroidism Hemolysis (consider LDH and Direct Coombs) Myelodysplastic syndrome Alcoholism, liver disease Medications

Macrocytic anemia continued Once the cause is determined, appropriate treatment can then be administered as indicated. Hematology evaluation is indicated if MDS or hemolytic anemia is suspected.

Normocytic Anemia MCV 80-100 Caused by: Bleeding Renal insufficiency Hemolysis (valve, TTP/HUS, DIC, autoimmune, etc.) Nutritional deficiency (yes iron, B12 and folate) Bone marrow disorders Anemia of Chronic Inflammation (here too- both micro and normo cytic )

Normocytic anemia If the work-up excludes bleeding, nutritional deficits, renal insufficiency, hemolysis, then the anemia is related to chronic disease or a primary bone marrow disorder. Evaluation for hemolysis: Schistocytes or spherocytes on smear Haptoglobin, Lactate dehydrogenase (LDH), Direct coombs, indirect bilirubin, and reticulocyte count. Consider drug-induced.

Polycythemia Suspected when Hgb and Hct are elevated. Primary Polycythemia (Polycythemia rubra vera; PV) Is a myeloproliferative disorder of the bone marrow. Secondary Polycythemia Caused by increased EPO levels due to hypoxia or an EPO producing tumor. Relative Polycythemia Caused by a decreased plasma volume increasing Hgb, Hct and RBC count.

Laboratory evaluation of Polycythemia Carboxyhemoglobin levels Elevated in smokers Erythropoietin levels Elevated Suggests erythropoietin producing tumor Low is characteristic of Polycythemia Vera JAK 2 testing Diagnostic for Myeloproliferative Disorder and Polycythemia Rubra Vera.

In summary If the patient feels sick and has abnormal blood counts..be worried and refer. If the patient has more than 1cell line abnormal even if they don t feel bad.be worried and refer. If the laboratory result does not fit with the clinical situation, recheck. Consider running CBC in heparin instead of EDTA.

In Summary continued If the patient has mildly low abnormalities and feels fine..consider watching and waiting. Pay attention to the work-ups that your friendly hematologist does on your patients. This will improve your initial work-up overtime.